Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Mall REITs: Shop Till You Drop

01:00pm, Tuesday, 18'th Aug 2020
From bad to worse. Entering 2020 on already unstable footing following a tsunami of store closings over the past half-decade, mall REITs have been punished by the ongoing coronavirus pandemic.
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) Catalent Inc (NYSE: CTLT) CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday

No Deal, No Problem

01:00pm, Saturday, 08'th Aug 2020
U.S. equity markets continued their seemingly relentless rally this week despite a stalemate in stimulus negotiations as an encouraging slate of employment data quelled concerns about an ebbing recove
How Nike rejection birthed sports wear industry in Nigeria Sports
Kymera Therapeutics has filed to raise $100 million in an IPO, although the final figure may vary. The firm is advancing drug treatment candidates for skin conditions and cancers.
CBL Properties (NYSE:CBL) today announced that its portfolio of market-dominant regional shopping centers will remain closed on Thanksgiving Day for t
CBL Properties (NYSE:CBL) today announced that the Company plans to issue its report of earnings for the second quarter 2020 after the close of market
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) Axonics Modulation Technologies Inc (NASDAQ: AXNX) Capricor Therapeutics Inc (NASDAQ: CAPR) Fulgent Genetics Inc...
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
Seven IPOs and five SPACs entered public markets this past week, led by high-flying Jamf Holding and the largest SPAC ever Pershing Square Tontine Holdings.
Nurix Therapeutics Inc. shares fell 2.3% in their trading debut Friday, after pricing above the proposed price range. Nurix sold 11 million shares priced at $19 each, above a recently tweaked $17 to
SAN FRANCISCO, July 23, 2020 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nurix), a company developing targeted protein modulation drugs, today announced the pricing of its initial public offering o
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE